PURPOSE: To provide medication safety tips to optimize the management of patients receiving treatment for chronic hepatitis C virus (HCV) infection. SUMMARY: Ensuring safe medication use in patients who receive treatment for HCV infection is a crucial component in providing optimal patient care. Because of the complexity of available treatment options, numerous challenges exist in preventing medication errors with HCV therapies. This article will focus on the selection of appropriate treatment options along with proper dosing and duration, awareness of concomitant disease states and drug interactions, identifying adverse drug reactions (ADRs) and patient counseling points, the provision of adherence counseling and prevention of treatment interruptions, improving communication with patients and between pharmacies, and recognizing the importance of a multidisciplinary approach. CONCLUSION: Maintaining awareness of medication safety strategies geared toward HCV pharmacotherapy is critical for providing optimal care for patients while minimizing the opportunity for errors.
PURPOSE: To provide medication safety tips to optimize the management of patients receiving treatment for chronic hepatitis C virus (HCV) infection. SUMMARY: Ensuring safe medication use in patients who receive treatment for HCV infection is a crucial component in providing optimal patient care. Because of the complexity of available treatment options, numerous challenges exist in preventing medication errors with HCV therapies. This article will focus on the selection of appropriate treatment options along with proper dosing and duration, awareness of concomitant disease states and drug interactions, identifying adverse drug reactions (ADRs) and patient counseling points, the provision of adherence counseling and prevention of treatment interruptions, improving communication with patients and between pharmacies, and recognizing the importance of a multidisciplinary approach. CONCLUSION: Maintaining awareness of medication safety strategies geared toward HCV pharmacotherapy is critical for providing optimal care for patients while minimizing the opportunity for errors.
Entities:
Keywords:
hepatitis C virus (HCV); medication errors; medication safety
Authors: Rochelle R Henderson; Jay Visaria; Gail G Bridges; Mary Dorholt; Rebecca J Levin; Sharon Glave Frazee Journal: J Manag Care Spec Pharm Date: 2014-12
Authors: Rima A Mohammad; Marilyn N Bulloch; Juliana Chan; Paulina Deming; Bryan Love; Lisa Smith; Betty J Dong Journal: Pharmacotherapy Date: 2014-10-31 Impact factor: 4.705
Authors: José Antonio Carrión; Elena Gonzalez-Colominas; Montserrat García-Retortillo; Nuria Cañete; Isabel Cirera; Susanna Coll; Maria Dolors Giménez; Carmen Márquez; Victoria Martin-Escudero; Pere Castellví; Ricard Navinés; Juan Ramon Castaño; Josep Anton Galeras; Esther Salas; Felipe Bory; Rocío Martín-Santos; Ricard Solà Journal: J Hepatol Date: 2013-06-26 Impact factor: 25.083
Authors: Donna M Evon; Carol E Golin; Jason E Bonner; Catherine Grodensky; Jennifer Velloza Journal: J Clin Gastroenterol Date: 2015 May-Jun Impact factor: 3.062
Authors: Paulina Deming; Michelle T Martin; Juliana Chan; Thomas J Dilworth; Rania El-Lababidi; Bryan L Love; Rima A Mohammad; Amy Nguyen; Linda M Spooner; Suzanne B Wortman Journal: Pharmacotherapy Date: 2016-02-05 Impact factor: 4.705